Document Detail

Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.
MedLine Citation:
PMID:  22305847     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Pentraxin-3 (PTX3) is an inflammatory marker thought to be more specific to vascular inflammation than C-reactive protein (CRP). Whether PTX3 is independently associated with adverse events among persons with stable coronary heart disease (CHD), independently of CRP, and whether kidney dysfunction influences these associations are not known.
METHODS: We evaluated the associations of baseline PTX3 levels with all-cause mortality, cardiovascular (CV) events (myocardial infarction, stroke, or CHD death), and incident heart failure (HF) during 37 months among ambulatory persons with stable CHD participating in the Heart and Soul Study. Cox proportional hazards models were adjusted for age, sex, race, hypertension, diabetes, smoking, and CRP.
RESULTS: Among 986 persons with stable CHD, each 1 unit increase in log PTX3 at baseline was associated with an 80% increased risk of all-cause mortality (hazard ratio [HR] 1.8, 95% CI 1.5-2.1), a 50% increased risk of CV events (HR 1.5, 95% CI, 1.2-1.9), and an 80% greater risk of incident HF (HR 1.8, 95% CI, 1.3-2.5). Further adjustment for estimated glomerular filtration rate (eGFR) attenuated these associations to 1.6 (1.3-1.9) for mortality, 1.3 (1.0-1.6) for CV events and 1.5 (1.1-2.1) for incident HF. Stratification by eGFR >60 mL/min per 1.73m(2) or <60 mL/min per 1.73m(2) did not affect these associations (P interaction > .3 for all outcomes).
CONCLUSIONS: Among persons with stable CHD, higher PTX3 concentrations were associated with increased risk for all-cause mortality, CV events, and incident HF independently of systemic inflammation. Adjustment for eGFR modestly attenuated these associations, suggesting that future studies of PTX3 should adjust for kidney function.
Ruth Dubin; Yongmei Li; Joachim H Ix; Michael G Shlipak; Mary Whooley; Carmen A Peralta
Related Documents :
22305847 - Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mor...
12020487 - Improved outcomes for women undergoing contemporary percutaneous coronary intervention:...
22635057 - Assessing and managing metabolic syndrome and cardiovascular risk in midlife women.
9202367 - Influence of cardiovascular risk status on coronary flow reserve in healthy young men.
22438937 - Social determinants of health and tobacco use in thirteen low and middle income countri...
14573727 - High local unemployment and increased mortality in danish adults; results from a prospe...
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study    
Journal Detail:
Title:  American heart journal     Volume:  163     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-06     Completed Date:  2012-03-27     Revised Date:  2014-09-08    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  274-9     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2012 Mosby, Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute-Phase Proteins
Biological Markers / blood
C-Reactive Protein / metabolism*
Coronary Disease / blood,  complications,  mortality*
Disease Progression
Follow-Up Studies
Heart Failure / blood,  epidemiology*,  etiology
Middle Aged
Proportional Hazards Models
Prospective Studies
Risk Factors
Serum Amyloid P-Component / metabolism*
Survival Rate / trends
United States / epidemiology
Grant Support
Reg. No./Substance:
0/Acute-Phase Proteins; 0/Biological Markers; 0/Serum Amyloid P-Component; 148591-49-5/PTX3 protein; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Frequency and impact of lifestyle modification in patients with coronary artery disease: The Japanes...
Next Document:  Cardiopulmonary exercise function among patients undergoing transcatheter pulmonary valve implantati...